Steven Cohen’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.8M Buy
158,400
+150,000
+1,786% +$22.5M 0.03% 757
2026
Q1
$1.28M Buy
8,400
+6,800
+425% +$1.04M ﹤0.01% 2596
2025
Q4
$221K Hold
1,600
﹤0.01% 3599
2025
Q3
$205K Buy
+1,600
New +$195K ﹤0.01% 2130
2024
Q4
Sell
-100,000
Closed -$11.5M 2336
2024
Q3
$11.5M Buy
+100,000
New +$11.3M 0.03% 600

Other funds holding NVS

Steven Cohen's NVS Position: Q2 2026 in Review

Steven Cohen reduced its Novartis (NVS) stake by 63% in Q2 2026, selling an estimated $26.6M and leaving 106,157 shares worth $16.6M. The position accounts for 0.02% of the portfolio, ranked #986.

Steven Cohen first reported a position in NVS in Q2 2014 and has held it in 23 quarters since. The position peaked at $167M in Q1 2023. 1,615 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Steven Cohen held 106,157 shares of Novartis worth $16.6M as of Q2 2026.
  • Steven Cohen sold 177,680 Novartis shares in Q2 2026, an estimated $26.6M.
  • Novartis made up 0.02% of Steven Cohen's portfolio in Q2 2026, its #986 holding.
  • Steven Cohen first reported a position in Novartis in Q2 2014 and has held it in 23 quarters since.
  • Steven Cohen's Novartis position peaked at $167M in Q1 2023.
  • 1,615 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.